Promising target for CAR-T cell therapy in digestive cancers

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Sep 21 / Springer Healthcare

Promising target for CAR-T cell therapy in digestive cancers

Oncology Gastrointestinal Cancer ESMO-2021

Description

Elizabeth Smyth comments on research looking at the potential of CLDN18.2 as a target for CAR-T cell targeting in patients with cancers of the digestive system.

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.